INS and metabolic syndrome: Another clinical trial [32] in 472 subjects with metabolic syndrome from eight European countries reported that the highest HOMA-R group, one of three groups classified by HOMA-R levels, had the greatest reduction in HOMA-R and insulin levels after consumption of a high MUFA diet or a diet supplemented with n-3 PUFA.